India Builds In Transaction Audits For Monitoring E-Pharmacies
Executive Summary
Transaction audits are proposed as part of checks to monitor e-pharmacies in India, though there are some concerns on whether the well-meaning measure can become a source of “inspector raj” and stifle the fledgling industry.
You may also be interested in...
Heat On E-Pharmacies In India -The Shape Of Things To Come
India is expected to rein in the ‘unfettered’ run of e-pharmacies, a segment where top Indian conglomerates and Amazon have made strides, with pharma intertwined having tapped into these platforms. Scrip speaks to experts on areas of concern including prescription ‘workarounds’, supply chain transparency and data privacy where more oversight is called for amid the evolving regulatory landscape.
2021 Deal Action In India: Watch Private Equity And E-Pharmacy
Most roads led to India in 2020 when it came to deals to expand access to COVID-19 therapies, but the challenging year also saw significant private equity interest and there are expectations of more action ahead in the new year.
Amazon Pharmacy Starting Up In India: What Pharma Could Gain Or Lose
Amazon Pharmacy’s debut in India could recalibrate and disrupt drug dispensing and distribution in the country, while also tempering investment flow in the e-pharmacy segment. Some experts also predict a squeeze on pharma’s profits.